Advertisement
Advertisement
U.S. markets open in 5 hours 40 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Arcadia Biosciences, Inc. (RKDA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
1.0300+0.0325 (+3.26%)
At close: 04:00PM EDT
1.0100 -0.02 (-1.94%)
After hours: 06:30PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/28/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.17
52-Week Change 3-65.89%
S&P500 52-Week Change 3-9.13%
52 Week High 33.0950
52 Week Low 30.7400
50-Day Moving Average 31.1225
200-Day Moving Average 31.3936

Share Statistics

Avg Vol (3 month) 3607.48k
Avg Vol (10 day) 3307.87k
Shares Outstanding 522.19M
Implied Shares Outstanding 6N/A
Float 821.04M
% Held by Insiders 17.98%
% Held by Institutions 18.67%
Shares Short (May 30, 2022) 4712.58k
Short Ratio (May 30, 2022) 41.02
Short % of Float (May 30, 2022) 43.21%
Short % of Shares Outstanding (May 30, 2022) 43.21%
Shares Short (prior month Apr 28, 2022) 4760.88k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 23, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 23, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -231.20%
Operating Margin (ttm)-270.62%

Management Effectiveness

Return on Assets (ttm)-28.31%
Return on Equity (ttm)-59.06%

Income Statement

Revenue (ttm)9.17M
Revenue Per Share (ttm)0.41
Quarterly Revenue Growth (yoy)288.90%
Gross Profit (ttm)1.57M
EBITDA -23.87M
Net Income Avi to Common (ttm)-21.21M
Diluted EPS (ttm)-0.9600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)24.55M
Total Cash Per Share (mrq)1.11
Total Debt (mrq)2.75M
Total Debt/Equity (mrq)9.08
Current Ratio (mrq)6.55
Book Value Per Share (mrq)1.36

Cash Flow Statement

Operating Cash Flow (ttm)-26.05M
Levered Free Cash Flow (ttm)-14.78M
Advertisement
Advertisement